Journey Medical Company Leadership
DERM Stock | USD 7.19 0.11 1.51% |
Journey Medical's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Journey Medical Corp suggests that most insiders are panicking. Journey Medical employs about 41 people. The company is managed by 12 executives with a total tenure of roughly 96 years, averaging almost 8.0 years of service per executive, having 3.42 employees per reported executive.
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-05-02 | Ramsey Alloush | Disposed 2857 @ 6.84 | View | ||
2025-03-11 | Claude Maraoui | Disposed 49271 @ 5.01 | View | ||
2025-03-07 | Claude Maraoui | Disposed 14905 @ 5.01 | View | ||
2025-03-05 | Claude Maraoui | Disposed 18147 @ 5.13 | View | ||
2025-03-03 | Claude Maraoui | Disposed 23508 @ 5.19 | View | ||
2024-08-01 | Joseph Benesch | Disposed 9324 @ 5.47 | View | ||
2024-07-23 | Joseph Benesch | Disposed 4055 @ 5.4 | View |
Monitoring Journey Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Journey Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.057) % which means that it has lost $0.057 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4814) %, meaning that it created substantial loss on money invested by shareholders. Journey Medical's management efficiency ratios could be used to measure how well Journey Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of July 2025, Return On Tangible Assets is likely to drop to -0.32. In addition to that, Return On Capital Employed is likely to drop to -0.32. At this time, Journey Medical's Total Assets are very stable compared to the past year. As of the 19th of July 2025, Other Current Assets is likely to grow to about 3.6 M, while Non Currrent Assets Other are likely to drop 5,130.As of the 19th of July 2025, Common Stock Shares Outstanding is likely to drop to about 18.6 M. In addition to that, Net Loss is likely to grow to about (25.3 M)
Journey Medical Workforce Comparison
Journey Medical Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,244. Journey Medical holds roughly 41.0 in number of employees claiming about 3% of equities under Health Care industry.
Journey Medical Profit Margins
The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.25) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.25.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.74 | 0.6281 |
|
|
Journey Medical Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Journey Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Journey Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Journey Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-09-01 | 2.5 | 5 | 2 | 68,912 | 13,379 |
2024-03-01 | 4.0 | 4 | 1 | 70,000 | 2,450 |
2023-12-01 | 0.6667 | 2 | 3 | 48,000 | 4,245 |
2023-09-01 | 3.5 | 7 | 2 | 265,932 | 24,839 |
2022-12-01 | 0.5 | 1 | 2 | 10,093 | 60,093 |
2022-09-01 | 7.0 | 7 | 1 | 521,225 | 50,000 |
2020-03-01 | 0.0139 | 1 | 72 | 40,926,025 | 1,496,497 |
2019-12-01 | 0.5 | 1 | 2 | 20,000 | 6,000 |
2019-09-01 | 0.4667 | 7 | 15 | 21,077 | 34,848 |
2019-06-01 | 1.75 | 21 | 12 | 162,000 | 162,019 |
2018-09-01 | 0.7143 | 10 | 14 | 175,150 | 20,392 |
2018-06-01 | 3.0 | 18 | 6 | 72,000 | 18,000 |
2018-03-01 | 0.8333 | 10 | 12 | 215,356 | 18,776 |
2017-09-01 | 0.5455 | 6 | 11 | 38,188 | 14,967 |
2017-06-01 | 1.75 | 14 | 8 | 55,000 | 9,500 |
2017-03-01 | 0.6154 | 8 | 13 | 241,500 | 10,500 |
2016-12-01 | 0.4 | 6 | 15 | 16,500 | 35,500 |
2016-09-01 | 0.4211 | 8 | 19 | 48,063 | 99,839 |
2016-06-01 | 2.0 | 6 | 3 | 58,616 | 7,500 |
2016-03-01 | 0.8 | 4 | 5 | 144,375 | 7,500 |
2015-09-01 | 0.5 | 1 | 2 | 20,689 | 22,500 |
2015-06-01 | 6.0 | 6 | 1 | 55,599 | 9,051 |
2014-12-01 | 0.6304 | 29 | 46 | 34,112,213 | 36,156,393 |
Journey Medical Notable Stakeholders
A Journey Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Journey Medical often face trade-offs trying to please all of them. Journey Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Journey Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Lindsay Rosenwald | Executive Chairman | Profile | |
Lindsay MD | Executive Chairman | Profile | |
Louis Donati | Director Access | Profile | |
CPA CPA | Chief Officer | Profile | |
Robyn Hunter | Treasurer Sec | Profile | |
Ernest Galvan | VP Strategy | Profile | |
Joseph Benesch | Interim Controller | Profile | |
Claude Maraoui | President, Founder | Profile | |
Robert Nevin | Chief Officer | Profile | |
Andrew Zwible | Vice Operations | Profile | |
Ramsey Alloush | General Secretary | Profile | |
Jaclyn Jaffe | Senior Operations | Profile |
About Journey Medical Management Performance
The success or failure of an entity such as Journey Medical Corp often depends on how effective the management is. Journey Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Journey management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Journey management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.30) | (0.32) | |
Return On Capital Employed | (0.30) | (0.32) | |
Return On Assets | (0.18) | (0.19) | |
Return On Equity | (0.73) | (0.69) |
Journey Medical Workforce Analysis
Traditionally, organizations such as Journey Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Journey Medical within its industry.Journey Medical Manpower Efficiency
Return on Journey Medical Manpower
Revenue Per Employee | 1.4M | |
Revenue Per Executive | 4.7M | |
Net Loss Per Employee | 357.9K | |
Net Loss Per Executive | 1.2M | |
Working Capital Per Employee | 317.2K | |
Working Capital Per Executive | 1.1M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share | Quarterly Revenue Growth 0.008 | Return On Assets | Return On Equity |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.